News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
267,727 Results
Type
Article (14264)
Company Profile (282)
Press Release (253181)
Section
Business (79715)
Career Advice (157)
Deals (13250)
Drug Delivery (35)
Drug Development (50473)
Employer Resources (31)
FDA (5737)
Job Trends (5151)
News (144701)
Policy (10054)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (919)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21733)
ALS (61)
Alzheimer's disease (836)
Antibody-drug conjugate (ADC) (88)
Approvals (5753)
Artificial intelligence (113)
Autoimmune disease (13)
Automation (5)
Bankruptcy (104)
Best Places to Work (4583)
BIOSECURE Act (5)
Biosimilars (40)
Biotechnology (232)
Bladder cancer (46)
Brain cancer (20)
Breast cancer (142)
Cancer (1319)
Cardiovascular disease (112)
Career advice (137)
Career pathing (2)
CAR-T (107)
Cell therapy (308)
Cervical cancer (8)
Clinical research (40941)
Collaboration (500)
Compensation (228)
Complete response letters (13)
COVID-19 (1035)
CRISPR (37)
C-suite (146)
Cystic fibrosis (76)
Data (1386)
Denatured (11)
Depression (29)
Diabetes (126)
Diagnostics (1317)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (79)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (83)
Earnings (29734)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48307)
Executive appointments (410)
FDA (6369)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (473)
Gene editing (90)
Generative AI (9)
Gene therapy (235)
GLP-1 (358)
Government (1079)
Grass and pollen (2)
Guidances (18)
Healthcare (6617)
Huntington's disease (21)
IgA nephropathy (22)
Immunology and inflammation (81)
Indications (18)
Infectious disease (1097)
Inflammatory bowel disease (110)
Inflation Reduction Act (8)
Influenza (18)
Intellectual property (58)
Interviews (17)
IPO (7275)
IRA (11)
Job creations (861)
Job search strategy (130)
Kidney cancer (6)
Labor market (4)
Layoffs (204)
Leadership (3)
Legal (1393)
Liver cancer (30)
Lung cancer (187)
Lymphoma (84)
Machine learning (1)
Management (7)
Manufacturing (116)
MASH (49)
Medical device (2624)
Medtech (2625)
Mergers & acquisitions (6274)
Metabolic disorders (366)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (61)
Neuropsychiatric disorders (23)
Neuroscience (1215)
NextGen: Class of 2025 (2022)
Non-profit (859)
Northern California (1580)
Now hiring (21)
Obesity (186)
Opinion (103)
Ovarian cancer (60)
Pain (41)
Pancreatic cancer (51)
Parkinson's disease (111)
Partnered (8)
Patents (112)
Patient recruitment (68)
Peanut (35)
People (25582)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14452)
Phase II (19039)
Phase III (12055)
Pipeline (744)
Podcasts (47)
Policy (39)
Postmarket research (852)
Preclinical (6070)
Press Release (30)
Prostate cancer (56)
Psychedelics (35)
Radiopharmaceuticals (212)
Rare diseases (277)
Real estate (1425)
Recruiting (12)
Regulatory (8592)
Reports (15)
Research institute (945)
Resumes & cover letters (18)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (56)
Series A (93)
Series B (60)
Service/supplier (1)
Sickle cell disease (39)
Southern California (1395)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1972)
State (1)
Stomach cancer (4)
Supply chain (18)
Tariffs (3)
The Weekly (35)
United States (12302)
Vaccines (205)
Venture capitalists (28)
Webinars (7)
Weight loss (105)
Women's health (15)
Worklife (2)
Date
Today (37)
Last 7 days (403)
Last 30 days (1564)
Last 365 days (19943)
2025 (4966)
2024 (20589)
2023 (22460)
2022 (26902)
2021 (27874)
2020 (23412)
2019 (16328)
2018 (11822)
2017 (13804)
2016 (11908)
2015 (14401)
2014 (10424)
2013 (7513)
2012 (7568)
2011 (7656)
2010 (7450)
Location
Africa (150)
Alabama (38)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17264)
Australia (2927)
California (3579)
Canada (1060)
China (326)
Colorado (138)
Connecticut (143)
Delaware (88)
Europe (37163)
Florida (423)
Georgia (110)
Idaho (16)
Illinois (215)
India (9)
Indiana (92)
Iowa (1)
Japan (71)
Kansas (60)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (447)
Massachusetts (2820)
Michigan (69)
Minnesota (138)
Mississippi (1)
Missouri (23)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (14)
New Jersey (894)
New Mexico (12)
New York (969)
North Carolina (525)
North Dakota (4)
Northern California (1580)
Ohio (109)
Oklahoma (9)
Oregon (21)
Pennsylvania (683)
Puerto Rico (3)
Rhode Island (15)
South America (211)
South Carolina (4)
Southern California (1395)
Tennessee (25)
Texas (412)
Utah (48)
Virginia (70)
Washington D.C. (28)
Washington State (327)
Wisconsin (13)
267,727 Results for "grid therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Infinimmune Announces Partnership with Grid Therapeutics to Conduct Deep Sequencing of B Cells for Oncology Drug Discovery
Infinimmune today announced a partnership with Grid Therapeutics (“Grid”), a clinical stage biotechnology company that focuses on human-derived antibodies, to collaborate in identifying new antibody drug candidates for non-small cell lung cancer.
December 19, 2023
·
3 min read
Biotech Bay
Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer
Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer.
May 22, 2024
·
5 min read
Press Releases
New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer Research
February 17, 2025
·
10 min read
Biotech Bay
Veracyte Announces that New Afirma GRID Data Suggest Prognostic Ability of Molecular Testing for Thyroid Tumors
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced new research findings suggesting the potential of novel molecular signatures to identify patients with thyroid nodules or cancer who have aggressive disease.
June 3, 2024
·
8 min read
Biotech Bay
Veracyte Announces that Findings Published in JCO Precision Oncology Suggest Potential of Decipher GRID-Derived Gene Signatures to Predict Treatment Response in Recurrent Prostate Cancer
Veracyte Announces that Findings Published in JCO Precision Oncology Suggest Potential of Decipher GRID-Derived Gene Signatures to Predict Treatment Response in Recurrent Prostate Cancer.
August 22, 2023
·
5 min read
Drug Development
Grid Therapeutics Initiates a Phase 2 Investigator-Sponsored Trial of GT103 in Combination with Merck’s Pembrolizumab in Patients with Advanced Stage Non-Small Cell Lung Cancer
Grid Therapeutics , LLC today announced the initiation of a combination Phase 2 investigator-sponsored study of its lead asset, GT103.
February 22, 2023
·
2 min read
Bio NC
Grid Therapeutics Announces Upcoming Scientific Presentation at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
Grid Therapeutics, LLC announced today a poster presentation at the Society for Immunotherapy of Cancer’s 37th Annual Meeting (SITC 2022), to be held in Boston, Massachusetts and virtually on November 8-12, 2022.
November 3, 2022
·
2 min read
Biotech Bay
New Data To Be Presented at 2023 ASCO GU Suggest Decipher GRID-Derived Gene Expression Signature Can Help Personalize Prostate Cancer Treatment
Veracyte, Inc. (Nasdaq: VCYT) announced new data being presented this week at the 2023 American Society of Clinical Oncology Genitourinary (ASCO GU) Symposium which demonstrate that a gene expression signature derived from the company’s proprietary Decipher Genomics Resource for Intelligent Discovery (GRID) database may help physicians further personalize treatment for men with prostate cancer, based on their tumor’s molecular subtype.
February 13, 2023
·
6 min read
Layoffs
Spark Therapeutics Cuts 298 Employees as Part of Reorganization
Roche’s reorganization of Spark Therapeutics is coming more into focus, with nearly 300 employees being let go by the end of this year. Spark also trimmed its staff in 2024.
April 4, 2025
·
1 min read
·
Angela Gabriel
Biotech Bay
New Data Suggest Decipher GRID-Derived Genomic Signature Can Help Identify Men with Prostate Cancer Who Should Receive High-Dose Radiotherapy
Veracyte, Inc . (Nasdaq: VCYT) announced new data demonstrating that a genomic signature derived from the company’s Decipher GRID database could help determine which men experiencing prostate cancer progression following radical prostatectomy (RP).
October 25, 2022
·
6 min read
1 of 26,773
Next
